Prolia (Amgen Inc)
Welcome to the PulseAid listing for the Prolia drug offered from Amgen Inc. This RANK Ligand Inhibitor [EPC],RANK Ligand Blocking Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amgen Inc |
| NON-PROPRIETARY NAME: | denosumab |
| SUBSTANCE NAME: | DENOSUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | RANK Ligand Inhibitor [EPC],RANK Ligand Blocking Activity [MoA] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2010-06-05 |
| END MARKETING DATE: | 0000-00-00 |
Prolia HUMAN PRESCRIPTION DRUG Details:
| Item Description | Prolia from Amgen Inc |
| LABELER NAME: | Amgen Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 60(mg/mL) |
| START MARKETING DATE: | 2010-06-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55513-710_f0a4aa32-b689-4a2a-b575-7b3156e79c0c |
| PRODUCT NDC: | 55513-710 |
| APPLICATION NUMBER: | BLA125320 |
Other DENOSUMAB Pharmaceutical Manufacturers / Labelers:
